Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program
Enliven Therapeutics' Phase 1 trial results for ELVN-001 in chronic myeloid leukemia (CML) patients. Explore the promising safety and efficacy data.
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday.
Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session.
Enliven Therapeutics Announces Proof Of Concept Data From Phase 1 Clinical Trial Of ELVN-001 In Chronic Myeloid Leukemia
Achieved initial cumulative MMR rate of 44% (7/16) by 12 weeks in response-evaluable patients, which compares favorably to precedent Phase 1 trials of approved BCR::ABL1 TKIs Achieved initial cumulative MMR rate of
Enliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says
Mizuho Securities initiates coverage on Enliven Therapeutics. Expectations high for late 2024 Phase 1 results. Enliven poised to revolutionize CML treatment, addressing current TKI limitations. Mizuho bullish with Buy rating, $34 price target. ELVN's trading value suggests conservative estimation compared to CML market potential.
Enliven Therapeutics To Share Initial Proof Of Concept Data From Phase 1 Clinical Trial Of ELVN-001 And Host Virtual Key Opinion Leader Event On April 11, 2024
Enliven Therapeutics, Inc. (Enliven or the Company) (NASDAQ:ELVN), a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors, today announced
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Moleculin Biotech (NASDAQ:MBRX) shares moved upwards by 8.7% to $0.72 during Tuesday’s after-market session. The market value…
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 212 companies made new 52-week lows.
Benzinga’s Top Ratings Upgrades, Downgrades For March 29, 2023
Upgrades According to Sidoti & Co., the prior rating for Federal Agricultural Mortgage Corp (NYSE:AGM) was changed from…